$DHR

Global pregnancy detection kits market projected to grow 41% from $1.91B (2025) to $2.69B (2031) amid tech advances, but faces accuracy and trust challenges.

Danaher Corporation approved a $0.40 per share quarterly dividend payable July 31, 2026, demonstrating ongoing shareholder return commitment.

Plasmid DNA manufacturing market projected to reach $10.8B by 2034 from $2.4B in 2025 on strong gene therapy demand growth.

Medtech giants aggressively acquiring AI diagnostic platforms as hospital adoption surges. $2.20B market projected by 2026 with 34.8% growth through 2033.

Cell culture media bags market projected to reach $2.28B by 2035 from $1.30B in 2025, growing at 5.8% CAGR amid biotech manufacturing expansion.

Global bulk filtration market expands through 2031 as environmental regulations, IoT integration, and smart technologies drive adoption across pharmaceuticals, water treatment, and industrial sectors.

Danaher trades 31% below historical valuation after 36% decline, but Masimo acquisition and resumed growth suggest recovery is underway for the storied life sciences leader.

Coagulation analyzer market projected to reach $7.87B by 2035 from $4.60B in 2025, driven by rising blood disorders and surgical volumes.

Global allergy diagnostic market projected to reach $10.77B by 2030 from $6.80B in 2025, driven by technological advances and rising allergies.

Global NGS market projected to reach $29.5B by 2030 from $14.9B in 2025, with Asia-Pacific experiencing fastest growth driven by precision medicine adoption.

Global molecular diagnostics market projected to grow from $18.26B in 2025 to $43.50B by 2035, driven by early disease detection demand and advanced technology adoption.

Global drug screening market projects 16.16% CAGR growth through 2031. Chromatography and mass spectrometry lead with 44.77% share; Asia-Pacific fastest growing.

Global pharmaceutical microbiology QC testing market projected to grow from $5.08B in 2025 to $17.65B by 2035, driven by automation and AI adoption.

Global molecular diagnostics market projected to reach $33.51B by 2031 at 10.43% CAGR, driven by precision medicine adoption and genomic testing advances.

Global microplate systems market projected to grow from $1.42B (2025) to $2.88B (2035) at 10.7% CAGR, driven by pharma R&D spending and automation demand.

Precision medicine market expected to double to $237.28B by 2031, driven by AI advances and biomarker development at 13.58% annual growth.

Danaher raises quarterly dividend to $0.40 per share, payable April 24, 2026, reflecting strong financial position and commitment to shareholder returns.

Major M&A wave reshapes industries: Danaher acquires Masimo for $9.9B, Devon completes $21.4B energy merger, while Starboard pressures TripAdvisor toward sale.

Danaher acquires Masimo for $9.9 billion in cash, expanding its medical technology portfolio with expected synergies exceeding $175 million annually.

Danaher to acquire Masimo for $9.9 billion, expanding its healthcare technology portfolio. The deal represents a significant premium and major consolidation in medical devices.